The FDA Is Failing – Here’s What Needs To Change
Daniel Aaron explains why premarket review isn’t as effective as it once was, how corporations have leveraged loopholes to skirt around regulations, and how the agency can get back on track.
Ketamine Regulations — “We Don’t Want To Reproduce This Opioid Problem”
Our expert shares the history of ketamine and how he believes it should be regulated to lessen the risk of addiction.
Medical Notes: February 13, 2022
An FDA-approved drug could help prevent memory loss in Alzheimer’s patients. Scientists discover why people with asthma are less likely to develop brain tumors. More than a third of Gulf War troops still suffer from Gulf War Illness, now a study shows that frequent exercise can help reduce symptoms. And finally, why are people moving back to their rural …
